Wednesday, October 22, 2025

Latest

Mind Cure Appoints Dr Ryan Hartwell As Chief Science Officer

Mind Cure Health (CSE: MCUR) has a new executive. The company this morning announced that appointment of Dr Ryan Hartwell as the firms Chief Science Officer. After months of serving on the firms scientific advisory board, Hartwell has taken the jump to lead the scientific team at the company.

A successful entrepeneur, scientist, inventor, and researcher, Hartwell appears to be highly qualified for the role. He previously founded ATS Biotech, a biomedical wound care company, while also acting as co-inventory of both FS2 and AI-001 cell therapy. Further, he also received the Vancouver Coastal Health Research Institute Award for top graduating doctoral student following the completion of his Ph.D. in experimental medicine at UBC.

Hartwell is to focus on the advancement of Mind Cure’s research and product development, and will be tasked with the role of leading efforts to research both psychoactive and psychedelic substances and their therapeutic benefits for the company. His role is to have a direct impact on establishing Mind Cure as a leader within the mental health space.

Commenting on the appointment, Hartwell stated, “From all that we have learned in studying psychedelics, the opportunity to chart a new path toward a better understanding and discovery of effective medicines provides tremendous potential to transform mental health and aging wellness.”

Mind Cure Health last traded at $0.64 on the CSE.


FULL DISCLOSURE: Mind Cure Health is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Mind Cure Health on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Steadright Enters MOU To Acquire Historic Goundafa Polymetallic Mine In Morocco

Military Seizes Power in Madagascar After President Flees

Related News

Mind Cure Sees Warrants Approved For Trading

Mind Cure Health (CSE: MCUR) is looking to provide a boost to its liquidity for...

Thursday, February 11, 2021, 09:32:23 AM

Mind Cure Health Receives Ethics Approval For Psychedelic Integration Protocol Study

Mind Cure Health (CSE: MCUR) has seen its integration protocol research study receive unconditional ethics...

Tuesday, March 9, 2021, 08:43:32 AM

Psychedelics & The Need For Digital Therapeutic Solutions In Treating Mental Health

In terms of investment dollar inflows, one of the largest focuses of 2020 has arguably...

Sunday, November 1, 2020, 09:00:00 AM

Mind Cure To See Nootropics Sold Across North America Via Body Energy Club

Mind Cure Health (CSE: MCUR) this morning released further plans related to the launch of...

Thursday, December 31, 2020, 09:17:25 AM

Mind Cure To Launch Psychedelic Assisted Mental Health Therapy Centre

Mind Cure Health (CSE: MCUR) is the latest issuer to become involved in operating psychedelic-assisted...

Thursday, December 10, 2020, 07:26:09 AM